Stock-Based Compensation - Restricted Stock (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Mar. 31, 2020 |
Sep. 30, 2019 |
|
| Unvested Restricted Stock | ||
| Outstanding as of September 30, 2019 | 6,875 | |
| Granted | 2,752 | |
| Vested | (6,502) | |
| Unvested as of March 31,2020 | 3,125 | |
| Total unrecognized expense remaining | $ 5,830 | |
| Weighted-average years expected to be recognized over | 2 months 12 days | |
| Weighted Grant Date Fair Value Price | ||
| Outstanding as of September 30, 2019 | $ 6.24 | $ 6.24 |
| Granted | 6.36 | |
| Vested | 6.29 | |
| Unvested as of March 31, 2020 | $ 6.24 | $ 6.24 |
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|